{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bordetella+Pertussis+Infection", "query": { "condition": "Bordetella Pertussis Infection" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 80, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bordetella+Pertussis+Infection&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-24T05:20:27.022Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01311557", "title": "Study of Adacel® Vaccine Administered to Persons 10 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis" ], "interventions": [ { "name": "Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "10 Years to 11 Years" }, "enrollment_count": 1302, "start_date": "2011-03", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 34, "location_summary": "Chandler, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 31 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Sacramento", "state": "California" }, { "city": "Longmont", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01311557" }, { "nct_id": "NCT00258882", "title": "Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pertussis" ], "interventions": [ { "name": "Tetanus Toxoid, acellular pertussis, diphtheria toxoid", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 327293, "start_date": "2006-01", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2018-07-17", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 3, "location_summary": "Oakland, California • Aurora, Colorado • Portland, Oregon", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00258882" }, { "nct_id": "NCT03463577", "title": "The Safety of Boostrix Following Routine Immunization of Pregnant Women", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Whooping Cough" ], "interventions": [ { "name": "Safety assessment following routine immunization with Boostrix", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 65783, "start_date": "2018-04-13", "completion_date": "2020-08-04", "has_results": true, "last_update_posted_date": "2022-05-18", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 1, "location_summary": "Pasadena, California", "locations": [ { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03463577" }, { "nct_id": "NCT00369824", "title": "Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Papillomavirus" ], "interventions": [ { "name": "Different formulations of GSK Biologicals' HPV vaccine (580299)", "type": "BIOLOGICAL" }, { "name": "Menactra TM", "type": "BIOLOGICAL" }, { "name": "Boostrix TM", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "FEMALE", "summary": "11 Years to 18 Years · Female only" }, "enrollment_count": 1330, "start_date": "2006-09-26", "completion_date": "2008-02-13", "has_results": true, "last_update_posted_date": "2018-07-20", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 50, "location_summary": "Mobile, Alabama • Chandler, Arizona • Mesa, Arizona + 46 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00369824" }, { "nct_id": "NCT01629589", "title": "Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis", "Whooping Cough" ], "interventions": [ { "name": "Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®)", "type": "BIOLOGICAL" }, { "name": "Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "11 Years to 12 Years" }, "enrollment_count": 423, "start_date": "2012-06", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2016-03-02", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 8, "location_summary": "Sacramento, California • Bardstown, Kentucky • Woburn, Massachusetts + 5 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Woburn", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Barnwell", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01629589" }, { "nct_id": "NCT02853617", "title": "A Study of AV0328 Administered to Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "PNAG-expressing Pathogenic Microbes Vaccine" ], "interventions": [ { "name": "AV0328 - Cohort 1", "type": "BIOLOGICAL" }, { "name": "AV0328 - Cohort 2", "type": "BIOLOGICAL" }, { "name": "AV0328 - Cohort 3", "type": "BIOLOGICAL" }, { "name": "AV0328 - Cohort 4", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Alopexx Vaccine, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2017-03-22", "completion_date": "2018-04-23", "has_results": false, "last_update_posted_date": "2019-03-19", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 1, "location_summary": "Neptune City, New Jersey", "locations": [ { "city": "Neptune City", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02853617" }, { "nct_id": "NCT00347958", "title": "Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis" ], "interventions": [ { "name": "Tetanus-diphtheria-acellular pertussis (Tdap) vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "15 Years to 69 Years" }, "enrollment_count": 545, "start_date": "2006-08", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2013-12-04", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 4, "location_summary": "Jonesboro, Arkansas • Bossier City, Louisiana • University Heights, Ohio + 1 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Bossier City", "state": "Louisiana" }, { "city": "University Heights", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00347958" }, { "nct_id": "NCT00467519", "title": "Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis" ], "interventions": [ { "name": "Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis)", "type": "BIOLOGICAL" }, { "name": "DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 1045, "start_date": "2007-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2014-02-07", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00467519" }, { "nct_id": "NCT01424644", "title": "A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meningococcal Meningitis" ], "interventions": [ { "name": "Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine", "type": "BIOLOGICAL" }, { "name": "MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 801, "start_date": "2011-09", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Fremont, California • Madera, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Madera", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Dayton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01424644" }, { "nct_id": "NCT02096263", "title": "Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Poliomyelitis", "Diphtheria", "Haemophilus Influenzae Type b", "Tetanus", "Acellular Pertussis", "Hepatitis B" ], "interventions": [ { "name": "Infanrix hexa", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pentacel", "type": "BIOLOGICAL" }, { "name": "Engerix-B", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevnar13", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 585, "start_date": "2014-04-16", "completion_date": "2015-11-13", "has_results": true, "last_update_posted_date": "2019-11-27", "last_synced_at": "2026-07-24T05:20:27.022Z", "location_count": 43, "location_summary": "Tucson, Arizona • Fayetteville, Arkansas • Anaheim, California + 38 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Daly City", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02096263" } ] }